메뉴 건너뛰기




Volumn 14, Issue 6, 2018, Pages 361-377

CKD in diabetes: Diabetic kidney disease versus nondiabetic kidney disease

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; SODIUM GLUCOSE COTRANSPORTER 2; SLC5A2 PROTEIN, HUMAN;

EID: 85045241847     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/s41581-018-0001-y     Document Type: Review
Times cited : (507)

References (163)
  • 1
    • 85051260971 scopus 로고    scopus 로고
    • IDF diabetes atlas-7th edition
    • International Diabetes Federation.
    • International Diabetes Federation. IDF Diabetes Atlas-7th Edition. Diabetes Atlas http:// www. diabetesatlas. org/ (2015).
    • (2015) Diabetes Atlas
  • 2
    • 85016474227 scopus 로고    scopus 로고
    • Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: A meta-analysis of individual participant data from randomised controlled trials
    • Zoungas, S. et al. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials. Lancet Diabetes Endocrinol 5, 431-437 (2017).
    • (2017) Lancet Diabetes Endocrinol , vol.5 , pp. 431-437
    • Zoungas, S.1
  • 3
    • 33750469241 scopus 로고    scopus 로고
    • Standards of medical care in diabetes 2017
    • American Diabetes, A.
    • American Diabetes, A. Standards of medical care in diabetes 2017. Diabetes Care 40, S1-S106 (2017).
    • (2017) Diabetes Care , vol.40 , pp. S1-S106
  • 4
    • 79952273819 scopus 로고    scopus 로고
    • Long-term effects of intensive glucose lowering on cardiovascular outcomes
    • Group, A. S. et al
    • Group, A. S. et al. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N. Engl. J. Med. 364, 818-828 (2011).
    • (2011) N. Engl. J. Med. , vol.364 , pp. 818-828
  • 5
    • 85014619872 scopus 로고    scopus 로고
    • Association of type 1 diabetes versus type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood
    • Dabelea, D. et al. Association of type 1 diabetes versus type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood. JAMA 317, 825-835 (2017).
    • (2017) JAMA , vol.317 , pp. 825-835
    • Dabelea, D.1
  • 6
    • 77950601556 scopus 로고    scopus 로고
    • Pathologic classification of diabetic nephropathy
    • Tervaert, T. W. et al. Pathologic classification of diabetic nephropathy. J. Am. Soc. Nephrol. 21, 556-563 (2010).
    • (2010) J. Am. Soc. Nephrol. , vol.21 , pp. 556-563
    • Tervaert, T.W.1
  • 8
    • 85019403451 scopus 로고    scopus 로고
    • Assessment of global kidney health care status
    • Bello, A. K. et al. Assessment of global kidney health care status. JAMA 317, 1864-1881 (2017).
    • (2017) JAMA , vol.317 , pp. 1864-1881
    • Bello, A.K.1
  • 9
    • 85013870239 scopus 로고    scopus 로고
    • US Renal Data System 2016 Annual Data Report: Epidemiology of kidney disease in the United States
    • Saran, R. et al. US Renal Data System 2016 Annual Data Report: Epidemiology of kidney disease in the United States. Am. J. Kidney Dis. 69, A7-A8 (2017).
    • (2017) Am. J. Kidney Dis. , vol.69 , pp. A7-A8
    • Saran, R.1
  • 10
    • 84978128484 scopus 로고    scopus 로고
    • Global Prevalence of chronic kidney disease-a systematic review and meta-analysis
    • Hill, N. R. et al. Global Prevalence of chronic kidney disease-a systematic review and meta-analysis. PLoS ONE 11, e0158765 (2016).
    • (2016) PLoS ONE , vol.11 , pp. e0158765
    • Hill, N.R.1
  • 12
    • 84885228643 scopus 로고    scopus 로고
    • The modern spectrum of renal biopsy findings in patients with diabetes
    • Sharma, S. G. et al. The modern spectrum of renal biopsy findings in patients with diabetes. Clin. J. Am. Soc. Nephrol. 8, 1718-1724 (2013).
    • (2013) Clin. J. Am. Soc. Nephrol. , vol.8 , pp. 1718-1724
    • Sharma, S.G.1
  • 13
    • 85016193736 scopus 로고    scopus 로고
    • Renal biopsy in patients with diabetes: A pooled meta-analysis of 48 studies
    • Fiorentino, M. et al. Renal biopsy in patients with diabetes: a pooled meta-analysis of 48 studies. Nephrol. Dial Transplant. 32, 97-110 (2017).
    • (2017) Nephrol. Dial Transplant. , vol.32 , pp. 97-110
    • Fiorentino, M.1
  • 14
    • 85018660023 scopus 로고    scopus 로고
    • Global kidney health 2017 and beyond: A roadmap for closing gaps in care, research, and policy
    • Levin, A. et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet 390, 1888-1917 (2017).
    • (2017) Lancet , vol.390 , pp. 1888-1917
    • Levin, A.1
  • 15
    • 85047123357 scopus 로고    scopus 로고
    • Diabetic Kidney Disease. the mechanisms and pathophysiology underlying diabetic nephropathy and its progression
    • [No authors listed. ]
    • [No authors listed. ] Diabetic Kidney Disease. The mechanisms and pathophysiology underlying diabetic nephropathy and its progression. National Institute of Diabetes and Digestive and Kidney Diseases https:// www. niddk. nih. gov/research-funding/researchprograms/ diabetic-kidney-disease (2018).
    • (2018) National Institute of Diabetes and Digestive and Kidney Diseases
  • 16
    • 84928210058 scopus 로고    scopus 로고
    • Diabetic nephropathy research in China: Data analysis and review from the National Natural Science Foundation of China
    • Wan, Q., Xu, Y. & Dong, E. Diabetic nephropathy research in China: Data analysis and review from the National Natural Science Foundation of China. J. Diabetes 7, 307-314 (2015).
    • (2015) J. Diabetes , vol.7 , pp. 307-314
    • Wan, Q.1    Xu, Y.2    Dong, E.3
  • 17
    • 85012031635 scopus 로고    scopus 로고
    • Diabetes control and the risks of ESRD and mortality in patients with CKD
    • Navaneethan, S. D. et al. Diabetes control and the risks of ESRD and mortality in patients with CKD. Am. J. Kidney Dis. 70, 191-198 (2017).
    • (2017) Am. J. Kidney Dis. , vol.70 , pp. 191-198
    • Navaneethan, S.D.1
  • 18
    • 84979884860 scopus 로고    scopus 로고
    • Cardiac and renovascular complications in type 2 diabetes-is there hope?
    • Ingelfinger, J. R. & Rosen, C. J. Cardiac and renovascular complications in type 2 diabetes-is there hope? N. Engl. J. Med. 375, 380-382 (2016).
    • (2016) N. Engl. J. Med. , vol.375 , pp. 380-382
    • Ingelfinger, J.R.1    Rosen, C.J.2
  • 19
    • 0032511566 scopus 로고    scopus 로고
    • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
    • Study (UKPDS) Group
    • Prospective Diabetes, U. K. Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352, 854-865 (1998).
    • (1998) Lancet , vol.352 , pp. 854-865
    • Prospective Diabetes, U.K.1
  • 20
    • 0035922441 scopus 로고    scopus 로고
    • Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
    • Brenner, B. M. et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 345, 861-869 (2001).
    • (2001) N. Engl. J. Med. , vol.345 , pp. 861-869
    • Brenner, B.M.1
  • 21
    • 84944800184 scopus 로고    scopus 로고
    • Empagliflozin, Cardiovascular outcomes, and mortality in type 2 diabetes
    • Zinman, B. et al. Empagliflozin, Cardiovascular outcomes, and mortality in type 2 diabetes. N. Engl. J. Med. 373, 2117-2128 (2015).
    • (2015) N. Engl. J. Med. , vol.373 , pp. 2117-2128
    • Zinman, B.1
  • 22
    • 85023777061 scopus 로고    scopus 로고
    • Canagliflozin and cardiovascular and renal events in type 2 diabetes
    • Neal, B. et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N. Engl. J. Med. 377, 644-657 (2017).
    • (2017) N. Engl. J. Med. , vol.377 , pp. 644-657
    • Neal, B.1
  • 23
    • 84978839381 scopus 로고    scopus 로고
    • Liraglutide and cardiovascular outcomes in type 2 diabetes
    • Marso, S. P. et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N. Engl. J. Med. 375, 311-322 (2016).
    • (2016) N. Engl. J. Med. , vol.375 , pp. 311-322
    • Marso, S.P.1
  • 24
    • 85018394748 scopus 로고    scopus 로고
    • Mortality and cardiovascular disease in type 1 and type 2 diabetes
    • Rawshani, A. et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N. Engl. J. Med. 376, 1407-1418 (2017).
    • (2017) N. Engl. J. Med. , vol.376 , pp. 1407-1418
    • Rawshani, A.1
  • 25
    • 84898602820 scopus 로고    scopus 로고
    • Changes in diabetes-related complications in the United States, 1990-2010
    • Gregg, E. W. et al. Changes in diabetes-related complications in the United States, 1990-2010. N. Engl. J. Med. 370, 1514-1523 (2014).
    • (2014) N. Engl. J. Med. , vol.370 , pp. 1514-1523
    • Gregg, E.W.1
  • 26
    • 0034951087 scopus 로고    scopus 로고
    • Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients
    • Parving, H. H., Hommel, E., Jensen, B. R. & Hansen, H. P. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients. Kidney Int. 60, 228-234 (2001).
    • (2001) Kidney Int. , vol.60 , pp. 228-234
    • Parving, H.H.1    Hommel, E.2    Jensen, B.R.3    Hansen, H.P.4
  • 27
    • 84863022503 scopus 로고    scopus 로고
    • Role of blood pressure and the renin-angiotensin system in development of diabetic nephropathy (DN) in eNOS/ db/db mice
    • Zhang, M. Z. et al. Role of blood pressure and the renin-angiotensin system in development of diabetic nephropathy (DN) in eNOS?/? db/db mice. Am. J. Physiol. Renal Physiol. 302, F433-F438 (2012).
    • (2012) Am. J. Physiol. Renal Physiol. , vol.302 , pp. F433-F438
    • Zhang, M.Z.1
  • 28
    • 84979895487 scopus 로고    scopus 로고
    • Empagliflozin and progression of kidney disease in type 2 diabetes
    • Wanner, C. et al. Empagliflozin and progression of kidney disease in type 2 diabetes. N. Engl. J. Med. 375, 323-334 (2016).
    • (2016) N. Engl. J. Med. , vol.375 , pp. 323-334
    • Wanner, C.1
  • 29
    • 85028547742 scopus 로고    scopus 로고
    • Liraglutide and renal outcomes in type 2 diabetes
    • Mann, J. F. E. et al. Liraglutide and renal outcomes in type 2 diabetes. N. Engl. J. Med. 377, 839-848 (2017).
    • (2017) N. Engl. J. Med. , vol.377 , pp. 839-848
    • Mann, J.F.E.1
  • 30
    • 84996993010 scopus 로고    scopus 로고
    • Nephron protection in diabetic kidney disease
    • Anders, H. J., Davis, J. M. & Thurau, K. Nephron protection in diabetic kidney disease. N. Engl. J. Med. 375, 2096-2098 (2016).
    • (2016) N. Engl. J. Med. , vol.375 , pp. 2096-2098
    • Anders, H.J.1    Davis, J.M.2    Thurau, K.3
  • 31
    • 0035922447 scopus 로고    scopus 로고
    • Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
    • Lewis, E. J. et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N. Engl. J. Med. 345, 851-860 (2001).
    • (2001) N. Engl. J. Med. , vol.345 , pp. 851-860
    • Lewis, E.J.1
  • 32
    • 0035922444 scopus 로고    scopus 로고
    • The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
    • Parving, H. H. et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N. Engl. J. Med. 345, 870-878 (2001).
    • (2001) N. Engl. J. Med. , vol.345 , pp. 870-878
    • Parving, H.H.1
  • 33
    • 84890946148 scopus 로고    scopus 로고
    • Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease
    • de Zeeuw, D. et al. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N. Engl. J. Med. 369, 2492-2503 (2013).
    • (2013) N. Engl. J. Med. , vol.369 , pp. 2492-2503
    • De Zeeuw, D.1
  • 34
    • 84869492851 scopus 로고    scopus 로고
    • Cardiorenal end points in a trial of aliskiren for type 2 diabetes
    • Parving, H. H. et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N. Engl. J. Med. 367, 2204-2213 (2012).
    • (2012) N. Engl. J. Med. , vol.367 , pp. 2204-2213
    • Parving, H.H.1
  • 35
    • 85021850104 scopus 로고    scopus 로고
    • Anti-TGF-?1 antibody therapy in patients with diabetic nephropathy
    • Voelker, J. et al. Anti-TGF-?1 antibody therapy in patients with diabetic nephropathy. J. Am. Soc. Nephrol. 28, 953-962 (2017).
    • (2017) J. Am. Soc. Nephrol. , vol.28 , pp. 953-962
    • Voelker, J.1
  • 36
    • 80053922229 scopus 로고    scopus 로고
    • Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death
    • Berhane, A. M., Weil, E. J., Knowler, W. C., Nelson, R. G. & Hanson, R. L. Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death. Clin. J. Am. Soc. Nephrol. 6, 2444-2451 (2011).
    • (2011) Clin. J. Am. Soc. Nephrol. , vol.6 , pp. 2444-2451
    • Berhane, A.M.1    Weil, E.J.2    Knowler, W.C.3    Nelson, R.G.4    Hanson, R.L.5
  • 37
    • 84874644599 scopus 로고    scopus 로고
    • KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease
    • Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group.
    • Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. Suppl. 3, 1-150 (2013).
    • (2013) Kidney Int. Suppl. , vol.3 , pp. 1-150
  • 38
    • 85033795749 scopus 로고    scopus 로고
    • Predictors for the development of microalbuminuria and interaction with renal function
    • Chatzikyrkou, C. et al. Predictors for the development of microalbuminuria and interaction with renal function. J. Hypertens. 35, 2501-2509 (2017).
    • (2017) J. Hypertens. , vol.35 , pp. 2501-2509
    • Chatzikyrkou, C.1
  • 39
    • 84866525978 scopus 로고    scopus 로고
    • Clinical implications of pathologic diagnosis and classification for diabetic nephropathy
    • Oh, S. W. et al. Clinical implications of pathologic diagnosis and classification for diabetic nephropathy. Diabetes Res. Clin. Pract. 97, 418-424 (2012).
    • (2012) Diabetes Res. Clin. Pract. , vol.97 , pp. 418-424
    • Oh, S.W.1
  • 40
    • 0037213037 scopus 로고    scopus 로고
    • Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)
    • Adler, A. I. et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 63, 225-232 (2003).
    • (2003) Kidney Int. , vol.63 , pp. 225-232
    • Adler, A.I.1
  • 41
    • 85021677814 scopus 로고    scopus 로고
    • Microalbuminuria in type-2 diabetes mellitus; The tip of iceberg of diabetic complications
    • Ahmad, T., Ulhaq, I., Mawani, M. & Islam, N. Microalbuminuria in type-2 diabetes mellitus; the tip of iceberg of diabetic complications. Pak. J. Med. Sci. 33, 519-523 (2017).
    • (2017) Pak. J. Med. Sci. , vol.33 , pp. 519-523
    • Ahmad, T.1    Ulhaq, I.2    Mawani, M.3    Islam, N.4
  • 42
    • 0021990584 scopus 로고
    • Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulindependent diabetes
    • Wiseman, M. J., Saunders, A. J., Keen, H. & Viberti, G. Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulindependent diabetes. N. Engl. J. Med. 312, 617-621 (1985).
    • (1985) N. Engl. J. Med. , vol.312 , pp. 617-621
    • Wiseman, M.J.1    Saunders, A.J.2    Keen, H.3    Viberti, G.4
  • 43
    • 84906695117 scopus 로고    scopus 로고
    • Improved glycemic control and risk of ESRD in patients with type 1 diabetes and proteinuria
    • Skupien, J. et al. Improved glycemic control and risk of ESRD in patients with type 1 diabetes and proteinuria. J. Am. Soc. Nephrol. 25, 2916-2925 (2014).
    • (2014) J. Am. Soc. Nephrol. , vol.25 , pp. 2916-2925
    • Skupien, J.1
  • 45
    • 85020448574 scopus 로고    scopus 로고
    • Glomerular hyperfiltration in diabetes: Mechanisms, clinical significance, and treatment
    • Tonneijck, L. et al. Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment. J. Am. Soc. Nephrol. 28, 1023-1039 (2017).
    • (2017) J. Am. Soc. Nephrol. , vol.28 , pp. 1023-1039
    • Tonneijck, L.1
  • 46
    • 84929223377 scopus 로고    scopus 로고
    • Genetics of diabetic nephropathy: A long road of discovery
    • McKnight, A. J., Duffy, S. & Maxwell, A. P. Genetics of diabetic nephropathy: a long road of discovery. Curr. Diab Rep. 15, 41 (2015).
    • (2015) Curr. Diab Rep. , vol.15 , pp. 41
    • McKnight, A.J.1    Duffy, S.2    Maxwell, A.P.3
  • 47
    • 84921374064 scopus 로고    scopus 로고
    • The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus
    • Vallon, V. The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus. Annu. Rev. Med. 66, 255-270 (2015).
    • (2015) Annu. Rev. Med. , vol.66 , pp. 255-270
    • Vallon, V.1
  • 48
    • 85035215727 scopus 로고    scopus 로고
    • A more tubulocentric view of diabetic kidney disease
    • Zeni, L., Norden, A. G. W., Cancarini, G. & Unwin, R. J. A more tubulocentric view of diabetic kidney disease. J. Nephrol. 30, 701-717 (2017).
    • (2017) J. Nephrol. , vol.30 , pp. 701-717
    • Zeni, L.1    Norden, A.G.W.2    Cancarini, G.3    Unwin, R.J.4
  • 50
    • 84922479673 scopus 로고    scopus 로고
    • Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: The Hoorn study
    • van Sloten, T. T. et al. Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study. Hypertension 64, 1299-1305 (2014).
    • (2014) Hypertension , vol.64 , pp. 1299-1305
    • Van Sloten, T.T.1
  • 51
    • 84902795323 scopus 로고    scopus 로고
    • Medical significance of endothelial glycocalyx. Part 2: Its role in vascular diseases and in diabetic complications [Spanish]
    • Frati Munari, A. C. Medical significance of endothelial glycocalyx. Part 2: Its role in vascular diseases and in diabetic complications [Spanish]. Arch. Cardiol. Mex. 84, 110-116 (2014).
    • (2014) Arch. Cardiol. Mex. , vol.84 , pp. 110-116
    • Frati Munari, A.C.1
  • 52
    • 84994098499 scopus 로고    scopus 로고
    • Glomerular endothelial cell injury and cross talk in diabetic kidney disease
    • Fu, J., Lee, K., Chuang, P. Y., Liu, Z. & He, J. C. Glomerular endothelial cell injury and cross talk in diabetic kidney disease. Am. J. Physiol. Renal Physiol. 308, F287-F297 (2015).
    • (2015) Am. J. Physiol. Renal Physiol. , vol.308 , pp. F287-F297
    • Fu, J.1    Lee, K.2    Chuang, P.Y.3    Liu, Z.4    He, J.C.5
  • 53
    • 33644759419 scopus 로고    scopus 로고
    • Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo
    • Nieuwdorp, M. et al. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 55, 480-486 (2006).
    • (2006) Diabetes , vol.55 , pp. 480-486
    • Nieuwdorp, M.1
  • 54
    • 0026680435 scopus 로고
    • Selective decreased de novo synthesis of glomerular proteoglycans under the influence of reactive oxygen species
    • Kashihara, N., Watanabe, Y., Makino, H., Wallner, E. I. & Kanwar, Y. S. Selective decreased de novo synthesis of glomerular proteoglycans under the influence of reactive oxygen species. Proc. Natl Acad. Sci. USA 89, 6309-6313 (1992).
    • (1992) Proc. Natl Acad. Sci. USA , vol.89 , pp. 6309-6313
    • Kashihara, N.1    Watanabe, Y.2    Makino, H.3    Wallner, E.I.4    Kanwar, Y.S.5
  • 55
    • 84872193981 scopus 로고    scopus 로고
    • Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc
    • Bock, F. et al. Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc. Proc. Natl Acad. Sci. USA 110, 648-653 (2013).
    • (2013) Proc. Natl Acad. Sci. USA , vol.110 , pp. 648-653
    • Bock, F.1
  • 56
    • 35948934636 scopus 로고    scopus 로고
    • Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis
    • Isermann, B. et al. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat. Med. 13, 1349-1358 (2007).
    • (2007) Nat. Med. , vol.13 , pp. 1349-1358
    • Isermann, B.1
  • 57
    • 0037407520 scopus 로고    scopus 로고
    • Extracellular matrix metabolism in diabetic nephropathy
    • Mason, R. M. & Wahab, N. A. Extracellular matrix metabolism in diabetic nephropathy. J. Am. Soc. Nephrol. 14, 1358-1373 (2003).
    • (2003) J. Am. Soc. Nephrol. , vol.14 , pp. 1358-1373
    • Mason, R.M.1    Wahab, N.A.2
  • 58
    • 85020453192 scopus 로고    scopus 로고
    • Accumulation of worn-out GBM material substantially contributes to mesangial matrix expansion in diabetic nephropathy
    • Kriz, W. et al. Accumulation of worn-out GBM material substantially contributes to mesangial matrix expansion in diabetic nephropathy. Am. J. Physiol. Renal Physiol. 312, F1101-F1111 (2017).
    • (2017) Am. J. Physiol. Renal Physiol. , vol.312 , pp. F1101-F1111
    • Kriz, W.1
  • 59
    • 0034608948 scopus 로고    scopus 로고
    • Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice
    • Ziyadeh, F. N. et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc. Natl Acad. Sci. USA 97, 8015-8020 (2000).
    • (2000) Proc. Natl Acad. Sci. USA , vol.97 , pp. 8015-8020
    • Ziyadeh, F.N.1
  • 60
    • 33644995630 scopus 로고    scopus 로고
    • High ambient glucose levels modulates the production of MMP-9 and alpha5(IV) collagen by cultured podocytes
    • Bai, Y. et al. High ambient glucose levels modulates the production of MMP-9 and alpha5(IV) collagen by cultured podocytes. Cell Physiol. Biochem. 17, 57-68 (2006).
    • (2006) Cell Physiol. Biochem. , vol.17 , pp. 57-68
    • Bai, Y.1
  • 61
    • 0035523642 scopus 로고    scopus 로고
    • Role of mesangial expansion in the pathogenesis of diabetic nephropathy
    • Dalla Vestra, M., Saller, A., Mauer, M. & Fioretto, P. Role of mesangial expansion in the pathogenesis of diabetic nephropathy. J. Nephrol. 14(Suppl. 4), S51-S57 (2001).
    • (2001) J. Nephrol. , vol.14 , pp. S51-S57
    • Dalla Vestra, M.1    Saller, A.2    Mauer, M.3    Fioretto, P.4
  • 62
    • 0031029379 scopus 로고    scopus 로고
    • Podocyte loss and progressive glomerular injury in type II diabetes
    • Pagtalunan, M. E. et al. Podocyte loss and progressive glomerular injury in type II diabetes. J. Clin. Invest. 99, 342-348 (1997).
    • (1997) J. Clin. Invest. , vol.99 , pp. 342-348
    • Pagtalunan, M.E.1
  • 63
    • 84864286521 scopus 로고    scopus 로고
    • Impact of high glucose and transforming growth factor-? on bioenergetic profiles in podocytes
    • Stieger, N. et al. Impact of high glucose and transforming growth factor-? on bioenergetic profiles in podocytes. Metabolism 61, 1073-1086 (2012).
    • (2012) Metabolism , vol.61 , pp. 1073-1086
    • Stieger, N.1
  • 64
    • 33644783770 scopus 로고    scopus 로고
    • Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy
    • Susztak, K., Raff, A. C., Schiffer, M. & Bottinger, E. P. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 55, 225-233 (2006).
    • (2006) Diabetes , vol.55 , pp. 225-233
    • Susztak, K.1    Raff, A.C.2    Schiffer, M.3    Bottinger, E.P.4
  • 65
    • 0031033557 scopus 로고    scopus 로고
    • Alterations in the expression of the alpha 3 beta 1 integrin in certain membrane domains of the glomerular epithelial cells (podocytes) in diabetes mellitus
    • Regoli, M. & Bendayan, M. Alterations in the expression of the alpha 3 beta 1 integrin in certain membrane domains of the glomerular epithelial cells (podocytes) in diabetes mellitus. Diabetologia 40, 15-22 (1997).
    • (1997) Diabetologia , vol.40 , pp. 15-22
    • Regoli, M.1    Bendayan, M.2
  • 66
    • 0034836835 scopus 로고    scopus 로고
    • Apoptosis in podocytes induced by TGF-? and Smad7
    • Schiffer, M. et al. Apoptosis in podocytes induced by TGF-? and Smad7. J. Clin. Invest. 108, 807-816 (2001).
    • (2001) J. Clin. Invest. , vol.108 , pp. 807-816
    • Schiffer, M.1
  • 67
    • 85016626296 scopus 로고    scopus 로고
    • SGLT2 Protein expression is increased in human diabetic nephropathy: SGLT2 protein inhibition decreases renal lipid accumulation, inflammation, and the development of nephropathy in diabetic mice
    • Wang, X. X. et al. SGLT2 Protein expression is increased in human diabetic nephropathy: SGLT2 protein inhibition decreases renal lipid accumulation, inflammation, and the development of nephropathy in diabetic mice. J. Biol. Chem. 292, 5335-5348 (2017).
    • (2017) J. Biol. Chem. , vol.292 , pp. 5335-5348
    • Wang, X.X.1
  • 68
    • 84937814929 scopus 로고    scopus 로고
    • Nephrin preserves podocyte viability and glomerular structure and function in adult kidneys
    • Li, X. et al. Nephrin preserves podocyte viability and glomerular structure and function in adult kidneys. J. Am. Soc. Nephrol. 26, 2361-2377 (2015).
    • (2015) J. Am. Soc. Nephrol. , vol.26 , pp. 2361-2377
    • Li, X.1
  • 69
    • 0345505674 scopus 로고    scopus 로고
    • Nephrin expression is reduced in human diabetic nephropathy: Evidence for a distinct role for glycated albumin and angiotensin II
    • Doublier, S. et al. Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 52, 1023-1030 (2003).
    • (2003) Diabetes , vol.52 , pp. 1023-1030
    • Doublier, S.1
  • 70
    • 79953840843 scopus 로고    scopus 로고
    • PKC mediates -arrestin2-dependent nephrin endocytosis in hyperglycemia
    • Quack, I. et al. PKC? mediates ?-arrestin2-dependent nephrin endocytosis in hyperglycemia. J. Biol. Chem. 286, 12959-12970 (2011).
    • (2011) J. Biol. Chem. , vol.286 , pp. 12959-12970
    • Quack, I.1
  • 71
    • 77956302476 scopus 로고    scopus 로고
    • Podocytic PKC- is regulated in murine and human diabetes and mediates nephrin endocytosis
    • Tossidou, I. et al. Podocytic PKC-? is regulated in murine and human diabetes and mediates nephrin endocytosis. PLoS ONE 5, e10185 (2010).
    • (2010) PLoS ONE , vol.5 , pp. e10185
    • Tossidou, I.1
  • 72
    • 85000613473 scopus 로고    scopus 로고
    • CIN85 Deficiency prevents nephrin endocytosis and proteinuria in diabetes
    • Teng, B. et al. CIN85 Deficiency prevents nephrin endocytosis and proteinuria in diabetes. Diabetes 65, 3667-3679 (2016).
    • (2016) Diabetes , vol.65 , pp. 3667-3679
    • Teng, B.1
  • 73
    • 84924371283 scopus 로고    scopus 로고
    • Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy
    • Madhusudhan, T. et al. Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy. Nat. Commun. 6, 6496 (2015).
    • (2015) Nat. Commun. , vol.6 , pp. 6496
    • Madhusudhan, T.1
  • 74
    • 85027712509 scopus 로고    scopus 로고
    • Signal integration at the PI3Kp85-XBP1 hub endows coagulation protease activated protein C with insulin-like function
    • Madhusudhan, T. et al. Signal integration at the PI3Kp85-XBP1 hub endows coagulation protease activated protein C with insulin-like function. Blood 130, 1445-1455 (2017).
    • (2017) Blood , vol.130 , pp. 1445-1455
    • Madhusudhan, T.1
  • 75
    • 77957657608 scopus 로고    scopus 로고
    • Insulin signaling to the glomerular podocyte is critical for normal kidney function
    • Welsh, G. I. et al. Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metab. 12, 329-340 (2010).
    • (2010) Cell Metab. , vol.12 , pp. 329-340
    • Welsh, G.I.1
  • 76
    • 29144490392 scopus 로고    scopus 로고
    • Podocyte depletion causes glomerulosclerosis: Diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene
    • Wharram, B. L. et al. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J. Am. Soc. Nephrol. 16, 2941-2952 (2005).
    • (2005) J. Am. Soc. Nephrol. , vol.16 , pp. 2941-2952
    • Wharram, B.L.1
  • 78
    • 84926644943 scopus 로고    scopus 로고
    • Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus
    • Fufaa, G. D. et al. Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus. Nephrol. Dial. Transplant. 30, 599-606 (2015).
    • (2015) Nephrol. Dial. Transplant. , vol.30 , pp. 599-606
    • Fufaa, G.D.1
  • 79
    • 84951905077 scopus 로고    scopus 로고
    • Innate immunity in diabetes and diabetic nephropathy
    • Wada, J. & Makino, H. Innate immunity in diabetes and diabetic nephropathy. Nat. Rev. Nephrol. 12, 13-26 (2016).
    • (2016) Nat. Rev. Nephrol. , vol.12 , pp. 13-26
    • Wada, J.1    Makino, H.2
  • 80
    • 85016026911 scopus 로고    scopus 로고
    • C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria
    • Menne, J. et al. C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria. Nephrol. Dial Transplant 32, 307-315 (2017).
    • (2017) Nephrol. Dial Transplant , vol.32 , pp. 307-315
    • Menne, J.1
  • 81
    • 84939483610 scopus 로고    scopus 로고
    • The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: A randomised trial
    • de Zeeuw, D. et al. The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial. Lancet Diabetes Endocrinol 3, 687-696 (2015).
    • (2015) Lancet Diabetes Endocrinol , vol.3 , pp. 687-696
    • De Zeeuw, D.1
  • 82
    • 26944480830 scopus 로고    scopus 로고
    • Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice
    • Chow, F. Y., Nikolic-Paterson, D. J., Ozols, E., Atkins, R. C. & Tesch, G. H. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J. Am. Soc. Nephrol. 16, 1711-1722 (2005).
    • (2005) J. Am. Soc. Nephrol. , vol.16 , pp. 1711-1722
    • Chow, F.Y.1    Nikolic-Paterson, D.J.2    Ozols, E.3    Atkins, R.C.4    Tesch, G.H.5
  • 83
    • 85027957604 scopus 로고    scopus 로고
    • An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes
    • Sayyed, S. G. et al. An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes. Kidney Int. 80, 68-78 (2011).
    • (2011) Kidney Int. , vol.80 , pp. 68-78
    • Sayyed, S.G.1
  • 84
    • 84920134906 scopus 로고    scopus 로고
    • Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy
    • Shahzad, K. et al. Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy. Kidney Int. 87, 74-84 (2015).
    • (2015) Kidney Int. , vol.87 , pp. 74-84
    • Shahzad, K.1
  • 85
    • 85007108941 scopus 로고    scopus 로고
    • Of inflammasomes and alarmins: IL-1? and IL-1? in kidney disease
    • Anders, H. J. Of inflammasomes and alarmins: IL-1? and IL-1? in kidney disease. J. Am. Soc. Nephrol. 27, 2564-2575 (2016).
    • (2016) J. Am. Soc. Nephrol. , vol.27 , pp. 2564-2575
    • Anders, H.J.1
  • 86
    • 84983319771 scopus 로고    scopus 로고
    • Targeting inflammation in diabetic kidney disease: Early clinical trials
    • Perez-Gomez, M. V. et al. Targeting inflammation in diabetic kidney disease: early clinical trials. Expert Opin. Invest. Drugs 25, 1045-1058 (2016).
    • (2016) Expert Opin. Invest. Drugs , vol.25 , pp. 1045-1058
    • Perez-Gomez, M.V.1
  • 87
    • 77649179433 scopus 로고    scopus 로고
    • NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?
    • Tschopp, J. & Schroder, K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat. Rev. Immunol. 10, 210-215 (2010).
    • (2010) Nat. Rev. Immunol. , vol.10 , pp. 210-215
    • Tschopp, J.1    Schroder, K.2
  • 88
    • 84903513560 scopus 로고    scopus 로고
    • Pattern recognition receptors and the inflammasome in kidney disease
    • Leemans, J. C., Kors, L., Anders, H. J. & Florquin, S. Pattern recognition receptors and the inflammasome in kidney disease. Nat. Rev. Nephrol. 10, 398-414 (2014).
    • (2014) Nat. Rev. Nephrol. , vol.10 , pp. 398-414
    • Leemans, J.C.1    Kors, L.2    Anders, H.J.3    Florquin, S.4
  • 89
    • 84994834565 scopus 로고    scopus 로고
    • Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy
    • Qiu, Y. Y. & Tang, L. Q. Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy. Pharmacol. Res. 114, 251-264 (2016).
    • (2016) Pharmacol. Res. , vol.114 , pp. 251-264
    • Qiu, Y.Y.1    Tang, L.Q.2
  • 90
    • 85017299727 scopus 로고    scopus 로고
    • Caspase-1, but not caspase-3, promotes diabetic nephropathy
    • Shahzad, K. et al. Caspase-1, but not caspase-3, promotes diabetic nephropathy. J. Am. Soc. Nephrol. 27, 2270-2275 (2016).
    • (2016) J. Am. Soc. Nephrol. , vol.27 , pp. 2270-2275
    • Shahzad, K.1
  • 91
    • 85029568219 scopus 로고    scopus 로고
    • Antiinflammatory therapy with canakinumab for atherosclerotic disease
    • Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119-1131 (2017).
    • (2017) N. Engl. J. Med. , vol.377 , pp. 1119-1131
    • Ridker, P.M.1
  • 92
    • 29144453326 scopus 로고    scopus 로고
    • Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
    • Nathan, D. M. et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N. Engl. J. Med. 353, 2643-2653 (2005).
    • (2005) N. Engl. J. Med. , vol.353 , pp. 2643-2653
    • Nathan, D.M.1
  • 93
    • 53349101264 scopus 로고    scopus 로고
    • Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia
    • El-Osta, A. et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J. Exp. Med. 205, 2409-2417 (2008).
    • (2008) J. Exp. Med. , vol.205 , pp. 2409-2417
    • El-Osta, A.1
  • 94
    • 84925519612 scopus 로고    scopus 로고
    • Epigenetic mechanisms in diabetic complications and metabolic memory
    • Reddy, M. A., Zhang, E. & Natarajan, R. Epigenetic mechanisms in diabetic complications and metabolic memory. Diabetologia 58, 443-455 (2015).
    • (2015) Diabetologia , vol.58 , pp. 443-455
    • Reddy, M.A.1    Zhang, E.2    Natarajan, R.3
  • 95
    • 14044252841 scopus 로고    scopus 로고
    • Gene-nutrient interactions in one-carbon metabolism
    • Friso, S. & Choi, S. W. Gene-nutrient interactions in one-carbon metabolism. Curr. Drug Metab. 6, 37-46 (2005).
    • (2005) Curr. Drug Metab. , vol.6 , pp. 37-46
    • Friso, S.1    Choi, S.W.2
  • 96
    • 33745074420 scopus 로고    scopus 로고
    • Impact of diets and nutrients/drugs on early epigenetic programming
    • Junien, C. Impact of diets and nutrients/drugs on early epigenetic programming. J. Inherit. Metab. Dis. 29, 359-365 (2006).
    • (2006) J. Inherit. Metab. Dis. , vol.29 , pp. 359-365
    • Junien, C.1
  • 97
    • 84903957218 scopus 로고    scopus 로고
    • MTORC1 maintains renal tubular homeostasis and is essential in response to ischemic stress
    • Grahammer, F. et al. mTORC1 maintains renal tubular homeostasis and is essential in response to ischemic stress. Proc. Natl Acad. Sci. USA 111, E2817-E2826 (2014).
    • (2014) Proc. Natl Acad. Sci. USA , vol.111 , pp. E2817-E2826
    • Grahammer, F.1
  • 98
    • 84878269299 scopus 로고    scopus 로고
    • MiR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes
    • Zhong, X. et al. miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia 56, 663-674 (2013).
    • (2013) Diabetologia , vol.56 , pp. 663-674
    • Zhong, X.1
  • 99
    • 84980383473 scopus 로고    scopus 로고
    • Roles of mTOR complexes in the kidney: Implications for renal disease and transplantation
    • Fantus, D., Rogers, N. M., Grahammer, F., Huber, T. B. & Thomson, A. W. Roles of mTOR complexes in the kidney: implications for renal disease and transplantation. Nat. Rev. Nephrol. 12, 587-609 (2016).
    • (2016) Nat. Rev. Nephrol. , vol.12 , pp. 587-609
    • Fantus, D.1    Rogers, N.M.2    Grahammer, F.3    Huber, T.B.4    Thomson, A.W.5
  • 100
    • 79957881425 scopus 로고    scopus 로고
    • Role of mTOR in podocyte function and diabetic nephropathy in humans and mice
    • Godel, M. et al. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J. Clin. Invest. 121, 2197-2209 (2011).
    • (2011) J. Clin. Invest. , vol.121 , pp. 2197-2209
    • Godel, M.1
  • 101
    • 85017435939 scopus 로고    scopus 로고
    • Targeting mTOR signaling can prevent the progression of FSGS
    • Zschiedrich, S. et al. Targeting mTOR signaling can prevent the progression of FSGS. J. Am. Soc. Nephrol. 28, 2144-2157 (2017).
    • (2017) J. Am. Soc. Nephrol. , vol.28 , pp. 2144-2157
    • Zschiedrich, S.1
  • 102
    • 85018371570 scopus 로고    scopus 로고
    • Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction
    • Qi, W. et al. Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction. Nat. Med. 23, 753-762 (2017).
    • (2017) Nat. Med. , vol.23 , pp. 753-762
    • Qi, W.1
  • 103
    • 84978765819 scopus 로고    scopus 로고
    • Obesity-related glomerulopathy: Clinical and pathologic characteristics and pathogenesis
    • D'Agati, V. D. et al. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat. Rev. Nephrol 12, 453-471 (2016).
    • (2016) Nat. Rev. Nephrol , vol.12 , pp. 453-471
    • D'Agati, V.D.1
  • 104
    • 85044198576 scopus 로고    scopus 로고
    • Reproductive health and pregnancy in women with chronic kidney disease
    • Wiles, K. S., Nelson-Piercy, C. & Bramham, K. Reproductive health and pregnancy in women with chronic kidney disease. Nat. Rev. Nephrol. https://doi. org/10. 1038/nrneph. 2017. 187 (2018).
    • (2018) Nat. Rev. Nephrol.
    • Wiles, K.S.1    Nelson-Piercy, C.2    Bramham, K.3
  • 105
    • 84948704559 scopus 로고    scopus 로고
    • Epidemiology of urinary tract infections in type 2 diabetes mellitus patients: An analysis based on a large sample of 456, 586 German T2DM patients
    • Wilke, T. et al. Epidemiology of urinary tract infections in type 2 diabetes mellitus patients: An analysis based on a large sample of 456, 586 German T2DM patients. J. Diabetes Compl. 29, 1015-1023 (2015).
    • (2015) J. Diabetes Compl. , vol.29 , pp. 1015-1023
    • Wilke, T.1
  • 106
    • 80052520550 scopus 로고    scopus 로고
    • Kidney biopsy in patients with diabetes mellitus
    • Haider, D. G. et al. Kidney biopsy in patients with diabetes mellitus. Clin. Nephrol. 76, 180-185 (2011).
    • (2011) Clin. Nephrol. , vol.76 , pp. 180-185
    • Haider, D.G.1
  • 107
    • 85018466835 scopus 로고    scopus 로고
    • Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012
    • Mayer-Davis, E. J. et al. Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012. N. Engl. J. Med. 376, 1419-1429 (2017).
    • (2017) N. Engl. J. Med. , vol.376 , pp. 1419-1429
    • Mayer-Davis, E.J.1
  • 108
    • 84873407159 scopus 로고    scopus 로고
    • Evaluation of renal biopsies in type 2 diabetic patients with kidney disease: A clinicopathological study of 216 cases
    • Zhuo, L., Ren, W., Li, W., Zou, G. & Lu, J. Evaluation of renal biopsies in type 2 diabetic patients with kidney disease: a clinicopathological study of 216 cases. Int. Urol. Nephrol. 45, 173-179 (2013).
    • (2013) Int. Urol. Nephrol. , vol.45 , pp. 173-179
    • Zhuo, L.1    Ren, W.2    Li, W.3    Zou, G.4    Lu, J.5
  • 109
    • 84906277024 scopus 로고    scopus 로고
    • Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: Recommendations and future directions
    • Sharif, A. et al. Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am. J. Transplant. 14, 1992-2000 (2014).
    • (2014) Am. J. Transplant. , vol.14 , pp. 1992-2000
    • Sharif, A.1
  • 110
    • 54949144323 scopus 로고    scopus 로고
    • Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients
    • International Diabetic Nephropathy Study.
    • Steinke, J. M. & Mauer, M., International Diabetic Nephropathy Study. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients. Pediatr. Endocrinol. Rev. 5(Suppl. 4), 958-963 (2008).
    • (2008) Pediatr. Endocrinol. Rev. , vol.5 , pp. 958-963
    • Steinke, J.M.1    Mauer, M.2
  • 111
    • 84897910668 scopus 로고    scopus 로고
    • Cystatin C-and creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the U
    • Tsai, C. W., Grams, M. E., Inker, L. A., Coresh, J. & Selvin, E. Cystatin C-and creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the U. S. Diabetes Care 37, 1002-1008 (2014).
    • (2014) S. Diabetes Care , vol.37 , pp. 1002-1008
    • Tsai, C.W.1    Grams, M.E.2    Inker, L.A.3    Coresh, J.4    Selvin, E.5
  • 112
    • 85035241193 scopus 로고    scopus 로고
    • Chronic kidney disease
    • Romagnani, P. et al. Chronic kidney disease. Nat. Rev. Dis. Primer 3, 17088 (2017).
    • (2017) Nat. Rev. Dis. Primer , vol.3 , pp. 17088
    • Romagnani, P.1
  • 113
    • 85031670298 scopus 로고    scopus 로고
    • A molecular morphometric approach to diabetic kidney disease can link structure to function and outcome
    • Nair, V. et al. A molecular morphometric approach to diabetic kidney disease can link structure to function and outcome. Kidney Int. 93, 439-449 (2018).
    • (2018) Kidney Int. , vol.93 , pp. 439-449
    • Nair, V.1
  • 114
    • 84883309399 scopus 로고    scopus 로고
    • Effect of losartan on prevention and progression of early diabetic nephropathy in American Indians with type 2 diabetes
    • Weil, E. J. et al. Effect of losartan on prevention and progression of early diabetic nephropathy in American Indians with type 2 diabetes. Diabetes 62, 3224-3231 (2013).
    • (2013) Diabetes , vol.62 , pp. 3224-3231
    • Weil, E.J.1
  • 115
    • 85020544173 scopus 로고    scopus 로고
    • Single-nephron glomerular filtration rate in healthy adults
    • Denic, A. et al. Single-nephron glomerular filtration rate in healthy adults. N. Engl. J. Med. 376, 2349-2357 (2017).
    • (2017) N. Engl. J. Med. , vol.376 , pp. 2349-2357
    • Denic, A.1
  • 116
    • 84860279587 scopus 로고    scopus 로고
    • Glomerular hyperfiltration: Definitions, mechanisms and clinical implications
    • Helal, I., Fick-Brosnahan, G. M., Reed-Gitomer, B. & Schrier, R. W. Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat. Rev. Nephrol. 8, 293-300 (2012).
    • (2012) Nat. Rev. Nephrol. , vol.8 , pp. 293-300
    • Helal, I.1    Fick-Brosnahan, G.M.2    Reed-Gitomer, B.3    Schrier, R.W.4
  • 117
    • 0032771641 scopus 로고    scopus 로고
    • What makes cells grow larger and how do they do it? Renal hypertrophy revisited
    • Preisig, P. What makes cells grow larger and how do they do it? Renal hypertrophy revisited. Exp. Nephrol. 7, 273-283 (1999).
    • (1999) Exp. Nephrol. , vol.7 , pp. 273-283
    • Preisig, P.1
  • 118
    • 85026894560 scopus 로고    scopus 로고
    • Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: The Gonryo study
    • Iwai, T. et al. Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study. Clin. Exp. Nephrol. https://doi. org/10. 1007/s10157-017-1451-4 (2017).
    • (2017) Clin. Exp. Nephrol.
    • Iwai, T.1
  • 119
    • 79955837851 scopus 로고    scopus 로고
    • Renal outcomes in patients with type 2 diabetes with or without coexisting non-diabetic renal disease
    • Chang, T. I. et al. Renal outcomes in patients with type 2 diabetes with or without coexisting non-diabetic renal disease. Diabetes Res. Clin. Pract. 92, 198-204 (2011).
    • (2011) Diabetes Res. Clin. Pract. , vol.92 , pp. 198-204
    • Chang, T.I.1
  • 120
    • 85035195459 scopus 로고    scopus 로고
    • The diabetes pandemic suggests unmet needs for 'CKD with diabetes' in addition to 'diabetic nephropathy'. Implications for pre-clinical research and drug testing
    • Anguiano Gomez, L., Lei, Y., Devarapu, S. K. & Anders, H. J. The diabetes pandemic suggests unmet needs for 'CKD with diabetes' in addition to 'diabetic nephropathy'. Implications for pre-clinical research and drug testing. Nephrol. Dial. Transplant. https:// doi. org/10. 1093/ndt/gfx219 (2017).
    • (2017) Nephrol. Dial. Transplant.
    • Anguiano Gomez, L.1    Lei, Y.2    Devarapu, S.K.3    Anders, H.J.4
  • 121
    • 84872047522 scopus 로고    scopus 로고
    • Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli
    • Hodgin, J. B. et al. Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli. Diabetes 62, 299-308 (2013).
    • (2013) Diabetes , vol.62 , pp. 299-308
    • Hodgin, J.B.1
  • 122
    • 85031747589 scopus 로고    scopus 로고
    • The establishment and validation of novel therapeutic targets to retard progression of chronic kidney disease
    • Pollock, C. et al. The establishment and validation of novel therapeutic targets to retard progression of chronic kidney disease. Kidney Int. Suppl. 7, 130-137 (2017).
    • (2017) Kidney Int. Suppl. , vol.7 , pp. 130-137
    • Pollock, C.1
  • 123
    • 84955324880 scopus 로고    scopus 로고
    • Hurdles to the introduction of new therapies for immunemediated kidney diseases
    • Anders, H. J., Jayne, D. R. & Rovin, B. H. Hurdles to the introduction of new therapies for immunemediated kidney diseases. Nat. Rev. Nephrol. 12, 205-216 (2016).
    • (2016) Nat. Rev. Nephrol. , vol.12 , pp. 205-216
    • Anders, H.J.1    Jayne, D.R.2    Rovin, B.H.3
  • 124
    • 85020353485 scopus 로고    scopus 로고
    • Risk factors for severe bleeding complications in percutaneous renal biopsy
    • Xu, D. M., Chen, M., Zhou, F. D. & Zhao, M. H. Risk factors for severe bleeding complications in percutaneous renal biopsy. Am. J. Med. Sci. 353, 230-235 (2017).
    • (2017) Am. J. Med. Sci. , vol.353 , pp. 230-235
    • Xu, D.M.1    Chen, M.2    Zhou, F.D.3    Zhao, M.H.4
  • 125
    • 85009742361 scopus 로고    scopus 로고
    • Kidney disease and obesity: Epidemiology, mechanisms and treatment
    • Camara, N. O., Iseki, K., Kramer, H., Liu, Z. H. & Sharma, K. Kidney disease and obesity: epidemiology, mechanisms and treatment. Nat. Rev. Nephrol. 13, 181-190 (2017).
    • (2017) Nat. Rev. Nephrol. , vol.13 , pp. 181-190
    • Camara, N.O.1    Iseki, K.2    Kramer, H.3    Liu, Z.H.4    Sharma, K.5
  • 126
    • 72049119396 scopus 로고    scopus 로고
    • Mouse models of diabetic nephropathy
    • Brosius, F. C. et al. Mouse models of diabetic nephropathy. J. Am. Soc. Nephrol. 20, 2503-2512 (2009).
    • (2009) J. Am. Soc. Nephrol. , vol.20 , pp. 2503-2512
    • Brosius, F.C.1
  • 127
    • 0034528381 scopus 로고    scopus 로고
    • Prevalence of non-diabetic renal disease among African-American patients with type II diabetes mellitus
    • Nzerue, C. M. et al. Prevalence of non-diabetic renal disease among African-American patients with type II diabetes mellitus. Scand. J. Urol. Nephrol. 34, 331-335 (2000).
    • (2000) Scand. J. Urol. Nephrol. , vol.34 , pp. 331-335
    • Nzerue, C.M.1
  • 128
    • 34250841698 scopus 로고    scopus 로고
    • Prevalence of nondiabetic renal disease in diabetic patients
    • Pham, T. T., Sim, J. J., Kujubu, D. A., Liu, I. L. & Kumar, V. A. Prevalence of nondiabetic renal disease in diabetic patients. Am. J. Nephrol. 27, 322-328 (2007).
    • (2007) Am. J. Nephrol. , vol.27 , pp. 322-328
    • Pham, T.T.1    Sim, J.J.2    Kujubu, D.A.3    Liu, I.L.4    Kumar, V.A.5
  • 129
    • 0036194517 scopus 로고    scopus 로고
    • Different patterns of renal damage in type 2 diabetes mellitus: A multicentric study on 393 biopsies
    • Mazzucco, G. et al. Different patterns of renal damage in type 2 diabetes mellitus: a multicentric study on 393 biopsies. Am. J. Kidney Dis. 39, 713-720 (2002).
    • (2002) Am. J. Kidney Dis. , vol.39 , pp. 713-720
    • Mazzucco, G.1
  • 130
    • 80052223047 scopus 로고    scopus 로고
    • Clinical versus histological diagnosis of diabetic nephropathy-is renal biopsy required in type 2 diabetic patients with renal disease?
    • Biesenbach, G., Bodlaj, G., Pieringer, H. & Sedlak, M. Clinical versus histological diagnosis of diabetic nephropathy-is renal biopsy required in type 2 diabetic patients with renal disease? QJM 104, 771-774 (2011).
    • (2011) QJM , vol.104 , pp. 771-774
    • Biesenbach, G.1    Bodlaj, G.2    Pieringer, H.3    Sedlak, M.4
  • 131
    • 0026551223 scopus 로고
    • Increased prevalence of renal biopsy findings other than diabetic glomerulopathy in type II diabetes mellitus
    • Richards, N. T. et al. Increased prevalence of renal biopsy findings other than diabetic glomerulopathy in type II diabetes mellitus. Nephrol. Dial Transplant 7, 397-399 (1992).
    • (1992) Nephrol. Dial Transplant , vol.7 , pp. 397-399
    • Richards, N.T.1
  • 132
    • 0033065531 scopus 로고    scopus 로고
    • Expansion of cortical interstitium is limited by converting enzyme inhibition in type 2 diabetic patients with glomerulosclerosis
    • Cordonnier, D. J. et al. Expansion of cortical interstitium is limited by converting enzyme inhibition in type 2 diabetic patients with glomerulosclerosis. J. Am. Soc. Nephrol. 10, 1253-1263 (1999).
    • (1999) J. Am. Soc. Nephrol. , vol.10 , pp. 1253-1263
    • Cordonnier, D.J.1
  • 133
    • 0026583232 scopus 로고
    • Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients
    • Parving, H. H. et al. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int. 41, 758-762 (1992).
    • (1992) Kidney Int. , vol.41 , pp. 758-762
    • Parving, H.H.1
  • 134
    • 0033797959 scopus 로고    scopus 로고
    • Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy
    • Christensen, P. K., Larsen, S., Horn, T., Olsen, S. & Parving, H. H. Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy. Kidney Int. 58, 1719-1731 (2000).
    • (2000) Kidney Int. , vol.58 , pp. 1719-1731
    • Christensen, P.K.1    Larsen, S.2    Horn, T.3    Olsen, S.4    Parving, H.H.5
  • 136
    • 85045291291 scopus 로고    scopus 로고
    • Predictive factors for non-diabetic nephropathy in diabetic patients. the utility of renal biopsy
    • Bermejo, S. et al. Predictive factors for non-diabetic nephropathy in diabetic patients. The utility of renal biopsy. Nefrologia 36, 535-544 (2016).
    • (2016) Nefrologia , vol.36 , pp. 535-544
    • Bermejo, S.1
  • 137
    • 0036837048 scopus 로고    scopus 로고
    • Is there a need for changes in renal biopsy criteria in proteinuria in type 2 diabetes?
    • Serra, A., Romero, R., Bayes, B., Lopez, D. & Bonet, J. Is there a need for changes in renal biopsy criteria in proteinuria in type 2 diabetes? Diabetes Res. Clin. Pract. 58, 149-153 (2002).
    • (2002) Diabetes Res. Clin. Pract. , vol.58 , pp. 149-153
    • Serra, A.1    Romero, R.2    Bayes, B.3    Lopez, D.4    Bonet, J.5
  • 138
    • 0036043660 scopus 로고    scopus 로고
    • Renal histological lesions in patients with type II diabetes mellitus [Spanish]
    • Castellano, I., Covarsi, A., Novillo, R., Gomez-Martino, J. R. & Ferrando, L. Renal histological lesions in patients with type II diabetes mellitus [Spanish]. Nefrologia 22, 162-169 (2002).
    • (2002) Nefrologia , vol.22 , pp. 162-169
    • Castellano, I.1    Covarsi, A.2    Novillo, R.3    Gomez-Martino, J.R.4    Ferrando, L.5
  • 139
    • 11244272941 scopus 로고    scopus 로고
    • The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994-2000
    • Rychlik, I. et al. The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994-2000. Nephrol. Dial. Transplant. 19, 3040-3049 (2004).
    • (2004) Nephrol. Dial. Transplant. , vol.19 , pp. 3040-3049
    • Rychlik, I.1
  • 140
    • 85047104701 scopus 로고    scopus 로고
    • Nondiabetic renal disease in patients with type 2 diabetes
    • Mami, I. et al. Nondiabetic renal disease in patients with type 2 diabetes. Saudi J. Kidney Dis. Transpl. 28, 842-850 (2017).
    • (2017) Saudi J. Kidney Dis. Transpl. , vol.28 , pp. 842-850
    • Mami, I.1
  • 141
    • 34248579004 scopus 로고    scopus 로고
    • Renal biopsy findings in diabetes mellitus [French]
    • Kharrat, M. et al. Renal biopsy findings in diabetes mellitus [French]. Tunis Med. 85, 216-219 (2007).
    • (2007) Tunis Med. , vol.85 , pp. 216-219
    • Kharrat, M.1
  • 142
    • 70350623080 scopus 로고    scopus 로고
    • Renal biopsy in patients with type 2 diabetes mellitus: Indications and nature of the lesions
    • Ghani, A. A., Al Waheeb, S., Al Sahow, A. & Hussain, N. Renal biopsy in patients with type 2 diabetes mellitus: indications and nature of the lesions. Ann. Saudi Med. 29, 450-453 (2009).
    • (2009) Ann. Saudi Med. , vol.29 , pp. 450-453
    • Ghani, A.A.1    Al Waheeb, S.2    Al Sahow, A.3    Hussain, N.4
  • 143
    • 79958140559 scopus 로고    scopus 로고
    • Pathology of nondiabetic glomerular disease among adult Iraqi patients from a single center
    • Hashim Al-Saedi, A. J. Pathology of nondiabetic glomerular disease among adult Iraqi patients from a single center. Saudi J. Kidney Dis. Transpl. 20, 858-861 (2009).
    • (2009) Saudi J. Kidney Dis. Transpl. , vol.20 , pp. 858-861
    • Hashim Al-Saedi, A.J.1
  • 144
    • 33845676163 scopus 로고    scopus 로고
    • Non diabetic renal disease in type 2 diabetes mellitus
    • Soni, S. S., Gowrishankar, S., Kishan, A. G. & Raman, A. Non diabetic renal disease in type 2 diabetes mellitus. Nephrology 11, 533-537 (2006).
    • (2006) Nephrology , vol.11 , pp. 533-537
    • Soni, S.S.1    Gowrishankar, S.2    Kishan, A.G.3    Raman, A.4
  • 145
    • 24044543553 scopus 로고    scopus 로고
    • Rapidly progressive renal failure in type 2 diabetes in the tropical environment: A clinico-pathological study
    • Moger, V. et al. Rapidly progressive renal failure in type 2 diabetes in the tropical environment: a clinico-pathological study. Ren. Fail. 27, 595-600 (2005).
    • (2005) Ren. Fail. , vol.27 , pp. 595-600
    • Moger, V.1
  • 146
    • 34249818454 scopus 로고    scopus 로고
    • Diabetic retinopathy is a poor predictor of type of nephropathy in proteinuric type 2 diabetic patients
    • Prakash, J. et al. Diabetic retinopathy is a poor predictor of type of nephropathy in proteinuric type 2 diabetic patients. J. Assoc. Physicians India 55, 412-416 (2007).
    • (2007) J. Assoc. Physicians India , vol.55 , pp. 412-416
    • Prakash, J.1
  • 147
    • 0036769974 scopus 로고    scopus 로고
    • Prevalence of non-diabetic renal disease in type 2 diabetic patients in a diabetes centre in Southern India
    • Premalatha, G. et al. Prevalence of non-diabetic renal disease in type 2 diabetic patients in a diabetes centre in Southern India. J. Assoc. Physicians India 50, 1135-1139 (2002).
    • (2002) J. Assoc. Physicians India , vol.50 , pp. 1135-1139
    • Premalatha, G.1
  • 148
    • 73349121664 scopus 로고    scopus 로고
    • An evaluation of renal biopsy in type-II diabetic patients
    • Arif, M., Arif, M. K. & Arif, M. S. An evaluation of renal biopsy in type-II diabetic patients. J. Coll. Physicians Surg. Pak 19, 627-631 (2009).
    • (2009) J. Coll. Physicians Surg. Pak , vol.19 , pp. 627-631
    • Arif, M.1    Arif, M.K.2    Arif, M.S.3
  • 149
    • 84871701298 scopus 로고    scopus 로고
    • Non-diabetic renal disease in patients with type-2 diabetes mellitus
    • Yaqub, S., Kashif, W. & Hussain, S. A. Non-diabetic renal disease in patients with type-2 diabetes mellitus. Saudi J. Kidney Dis. Transpl 23, 1000-1007 (2012).
    • (2012) Saudi J. Kidney Dis. Transpl , vol.23 , pp. 1000-1007
    • Yaqub, S.1    Kashif, W.2    Hussain, S.A.3
  • 150
    • 84863393841 scopus 로고    scopus 로고
    • Clinical predictors of non-diabetic renal disease and role of renal biopsy in diabetic patients with renal involvement: A single centre review
    • Chong, Y. B. et al. Clinical predictors of non-diabetic renal disease and role of renal biopsy in diabetic patients with renal involvement: a single centre review. Ren. Fail. 34, 323-328 (2012).
    • (2012) Ren. Fail. , vol.34 , pp. 323-328
    • Chong, Y.B.1
  • 151
    • 84990837137 scopus 로고    scopus 로고
    • Clinicopathological characteristics of nondiabetic renal disease in patients with type 2 diabetes mellitus in a northeastern Chinese medical center: A retrospective analysis of 273 cases
    • Liu, S. et al. Clinicopathological characteristics of nondiabetic renal disease in patients with type 2 diabetes mellitus in a northeastern Chinese medical center: a retrospective analysis of 273 cases. Int. Urol. Nephrol. 48, 1691-1698 (2016).
    • (2016) Int. Urol. Nephrol. , vol.48 , pp. 1691-1698
    • Liu, S.1
  • 152
    • 78651344471 scopus 로고    scopus 로고
    • Nondiabetic renal disease in type 2 diabetic patients: A review of our experience in 220 cases
    • Bi, H. et al. Nondiabetic renal disease in type 2 diabetic patients: a review of our experience in 220 cases. Ren. Fail. 33, 26-30 (2011).
    • (2011) Ren. Fail. , vol.33 , pp. 26-30
    • Bi, H.1
  • 153
    • 78650647192 scopus 로고    scopus 로고
    • Renal biopsy in type 2 diabetes: Timing of complications and evaluating of safety in Chinese patients
    • Zhang, P. P. et al. Renal biopsy in type 2 diabetes: timing of complications and evaluating of safety in Chinese patients. Nephrology 16, 100-105 (2011).
    • (2011) Nephrology , vol.16 , pp. 100-105
    • Zhang, P.P.1
  • 154
    • 77649187442 scopus 로고    scopus 로고
    • Prevalence of non-diabetic renal disease in patients with type 2 diabetes
    • Mou, S. et al. Prevalence of non-diabetic renal disease in patients with type 2 diabetes. Diabetes Res. Clin. Pract. 87, 354-359 (2010).
    • (2010) Diabetes Res. Clin. Pract. , vol.87 , pp. 354-359
    • Mou, S.1
  • 155
    • 0036582704 scopus 로고    scopus 로고
    • Renal outcome in type 2 diabetic patients with or without coexisting nondiabetic nephropathies
    • Wong, T. Y. et al. Renal outcome in type 2 diabetic patients with or without coexisting nondiabetic nephropathies. Diabetes Care 25, 900-905 (2002).
    • (2002) Diabetes Care , vol.25 , pp. 900-905
    • Wong, T.Y.1
  • 156
    • 34248395631 scopus 로고    scopus 로고
    • Renal pathological change in patients with type 2 diabetes is not always diabetic nephropathy: A report of 52 cases
    • Huang, F. et al. Renal pathological change in patients with type 2 diabetes is not always diabetic nephropathy: a report of 52 cases. Clin. Nephrol. 67, 293-297 (2007).
    • (2007) Clin. Nephrol. , vol.67 , pp. 293-297
    • Huang, F.1
  • 157
    • 0030665196 scopus 로고    scopus 로고
    • Clinical predictors of non-diabetic renal disease in patients with non-insulin dependent diabetes mellitus
    • Mak, S. K. et al. Clinical predictors of non-diabetic renal disease in patients with non-insulin dependent diabetes mellitus. Nephrol. Dial. Transplant. 12, 2588-2591 (1997).
    • (1997) Nephrol. Dial. Transplant. , vol.12 , pp. 2588-2591
    • Mak, S.K.1
  • 158
    • 67749088600 scopus 로고    scopus 로고
    • Clinical indicators which necessitate renal biopsy in type 2 diabetes mellitus patients with renal disease
    • Lin, Y. L., Peng, S. J., Ferng, S. H., Tzen, C. Y. & Yang, C. S. Clinical indicators which necessitate renal biopsy in type 2 diabetes mellitus patients with renal disease. Int. J. Clin. Pract. 63, 1167-1176 (2009).
    • (2009) Int. J. Clin. Pract. , vol.63 , pp. 1167-1176
    • Lin, Y.L.1    Peng, S.J.2    Ferng, S.H.3    Tzen, C.Y.4    Yang, C.S.5
  • 159
    • 84873203852 scopus 로고    scopus 로고
    • Significance of renal biopsy in patients with presumed diabetic nephropathy
    • Harada, K. et al. Significance of renal biopsy in patients with presumed diabetic nephropathy. J. Diabetes Investig. 4, 88-93 (2013).
    • (2013) J. Diabetes Investig. , vol.4 , pp. 88-93
    • Harada, K.1
  • 161
    • 23744472597 scopus 로고    scopus 로고
    • Clinical features of non-diabetic renal diseases in patients with type 2 diabetes
    • Tone, A. et al. Clinical features of non-diabetic renal diseases in patients with type 2 diabetes. Diabetes Res. Clin. Pract. 69, 237-242 (2005).
    • (2005) Diabetes Res. Clin. Pract. , vol.69 , pp. 237-242
    • Tone, A.1
  • 162
    • 47949126901 scopus 로고    scopus 로고
    • Microscopic hematuria and diabetic glomerulosclerosis-clinicopathological analysis of type 2 diabetic patients associated with overt proteinuria
    • Akimoto, T. et al. Microscopic hematuria and diabetic glomerulosclerosis-clinicopathological analysis of type 2 diabetic patients associated with overt proteinuria. Nephron Clin. Pract. 109, c119 (2008).
    • (2008) Nephron Clin. Pract. , vol.109 , pp. c119
    • Akimoto, T.1
  • 163
    • 0033176345 scopus 로고    scopus 로고
    • Non-diabetic renal disease in patients with non-insulin dependent diabetes mellitus
    • Lee, E. Y., Chung, C. H. & Choi, S. O. Non-diabetic renal disease in patients with non-insulin dependent diabetes mellitus. Yonsei Med. J. 40, 321-326 (1999).
    • (1999) Yonsei Med. J. , vol.40 , pp. 321-326
    • Lee, E.Y.1    Chung, C.H.2    Choi, S.O.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.